We're #hiring a new Scientist/Senior Scientist - Computational Biologist in Cambridge, Massachusetts. Apply today or share this post with your network.
GC Therapeutics
Biotechnology Research
Cambridge, MA 10,806 followers
A Path to SuperCells™ Therapies
About us
GC Therapeutics Inc. (GCTx) uses synthetic biology to program patient-derived stem cells into any cell type with best-in-class efficiency (up to 10X), speed (up to 100X) and scalability. We dictate cells fates in a single step and have validated cells for many applications. We have also developed SuperCells™ by tailoring cells for specific diseases. The core technology of GCTx was conceived, invented and perfected in Professor George Church’s lab at Harvard Medical School. We are a group of passionate biologists and tissue engineers whose goal is to bring this breakthrough approach to patients.
- Website
-
http://www.gc-tx.com
External link for GC Therapeutics
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Cambridge, MA
- Type
- Privately Held
Locations
-
Primary
Get directions
Cambridge, MA, US
Employees at GC Therapeutics
-
Iris (Hongguang) Huo
Process Development Scientist III at GC Therapeutics
-
Alex Ng, Ph.D.
Chief Scientific Officer and Co-Founder of GC Therapeutics
-
Chih-Chao Yang
Senior Scientist II, Process Development, GC Therapeutics
-
Parastoo Khoshakhlagh, Ph.D.
CEO & Co-Founder at GC Therapeutics
Updates
-
We're #hiring a new Research Associate, In Vivo Biology in Cambridge, Massachusetts. Apply today or share this post with your network.
-
We're #hiring a new Research Associate - Assay Development in Cambridge, Massachusetts. Apply today or share this post with your network.
-
We're #hiring a new Research Associate - Assay Development in Cambridge, Massachusetts. Apply today or share this post with your network.
-
We're #hiring a new Research Associate, Stem Cell Biology in Cambridge, Massachusetts. Apply today or share this post with your network.
-
We’re excited to announce our CEO and Co-Founder, Parastoo Khoshakhlagh, Ph.D., will be co-hosting the Boston leg of The Founder-Led Biotech Tour hosted by Pillar VC in Cambridge on Wednesday, November 20th! She will be joined by fellow top biotech founders and industry leaders - we hope you can join us to connect with these pioneers and be inspired by the movement. For more details: https://lnkd.in/gWhS5_4Y Special thanks to Thomas de Vlaam and Tony Kulesa for making this evening of networking and insights possible! #PillarVC #CambridgeMA #BostonEvents #Biotech #FounderLedBiotech #Networking #Innovation #BiotechLeaders #GCTx
-
-
We're #hiring a new Research Associate - Molecular Biology in Cambridge, Massachusetts. Apply today or share this post with your network.
-
We’re excited to share that our CEO, Parastoo Khoshakhlagh, Ph.D., a 2023 Termeer Fellow will be a featured panelist at an upcoming discussion on female leaders in biotech hosted by The Termeer Foundation and WEST - Women in the Enterprise of Science and Technology. This panel will explore the unique experiences, challenges, and successes of women stepping into leadership roles as executives and founders in the biotech industry. Parastoo will be joined by fellow inspiring female leaders Vered Bisker-Leib, Nele Van Dessel (Termeer Fellow), and Jo Viney. Special thanks to Rachele Ryan, Director of Partnerships at LabCentral for moderating! 📅 Date: November 6, 2024 🕒 Time: 8:00-10:00 AM ET 📍 Location: The Termeer Foundation, 1393 Boylston St., Boston, MA 02215 🔗 Learn more and register at https://lnkd.in/gUSNvzcm Join us for an empowering conversation that aims to uplift and celebrate women making waves in the world of biotech!
-
-
GC Therapeutics reposted this
Thrilled to have attended BioFuture for the third consecutive year! Last week, at the Cure. in New York City, #BioFuture 2024 gathered a remarkable community of trailblazers, disruptors, and investors from across the healthcare ecosystem to discuss the future of healthcare innovation. The conference spotlighted impactful discussions on AI/ML, quantum computing, policy advancements, neuroscience, oncology, obesity treatments, longevity, biomanufacturing, cell and gene therapy, cardiovascular health, women’s health, and financing strategies. We explored the convergence of deep tech and deep science in drug discovery & development, diving into the forefront of healthcare transformation. It was also the perfect opportunity to reconnect with fellow investors, founders, and ecosystem partners. Great to finally meet Parastoo Khoshakhlagh, Ph.D. in person and catch up with Tingting Zhang-Kharas, PhD, Silvia Garcia Codony, and Lynda Chin. A huge thanks to Sara Jane Demy and Demy-Colton for organizing such an inspiring event. Already looking forward to BioFuture 2025! #healthcare #biotech #lifescience #biopharma #TechBio #AI #Therapeutics #venturecapital #innovations #deeptech
-
-
Proud to announce that our CEO Parastoo Khoshakhlagh, Ph.D. will be speaking on the panel Emerging Technologies and Approaches in Cell & Gene Therapy at #BioFuture2024! With the field evolving at an incredible pace, emerging technologies like AI and machine learning are reshaping what we can achieve. She will be joined by Paul Bresge, Kate Rochlin, PhD and moderator Lei Lei Wu to discuss how these innovations are breaking through current limitations, enhancing precision, and speeding up the journey from research to real-world applications. Together, we're making strides toward more effective, accessible therapies that have the power to transform lives. Special thank you to Sara Jane Demy, Sara Pinto, and Kimberly Ha for the invitation and opportunity contribute to the discussion and explore the latest topics shaping the future of #healthcare. Join us for insightful conversations driving the next wave of breakthrough innovation. Register at www.BioFuture.com!
-